Curriculum · Toxicology and Emergency Care
Sepsis and septic shock resuscitation
What it is
The patient in septic shock is hypotensive, or has an elevated serum lactate, or both. Among the shock states it is the one with a high CO. Cardiogenic shock, hypovolemic shock, neurogenic shock and cardiac tamponade all sit on the low side of the same tree, and are separated further by HR, by PVR and by wedge pressure.
The goal of resuscitation is to restore perfusion, tissue oxygenation and hemodynamic stability. Early targeted therapy reduces mortality, which is why the fluid challenge is started as early as possible in the course of septic shock.
How it is diagnosed
Lactate does the work that blood pressure cannot. A serum lactate above 4 mmol/L is correlated with increased severity of illness and with poorer outcomes even if hypotension is not yet present, so a blood pressure that is still holding does not mean resuscitation can wait. A hypotensive patient and a patient whose serum lactate is raised are treated the same way.
A post-colectomy patient who is hypotensive with a lactate of 5 mmol/L is the worked example of septic shock.
How it is treated
Patients with an elevated serum lactate or hypotension receive isotonic intravenous fluids at an initial rate of 30 mL/kg in the first 3 hours, given as small boluses of approximately 500 mL. The 30 mL/kg is a fluid challenge, based on actual body weight, and the 2021 recommendation is at least 30 mL/kg of crystalloid within the first 3 hours for sepsis-induced hypoperfusion, as a strong recommendation. Patients who are hypotensive or whose serum lactate is raised need intravenous fluids or colloid to expand their circulating volume and effectively restore perfusion pressure.
The fluid is an isotonic crystalloid such as normal saline or lactated Ringer's solution, and balanced crystalloids such as Ringer's lactate or Plasma-Lyte are preferred over 0.9% saline, because of lower AKI risk and lower mortality in the SMART and SALT-ED trials.
Fluid is not the whole of it. Start the 30 mL/kg promptly, then reassess using dynamic measures and dynamic indices to guide further fluid, and escalate with vasopressors as needed. Consider 5 % albumin if large volumes are needed, above 30 to 40 mL/kg, or if shock persists; it is beneficial in hypoalbuminemia but it is not first-line.
In pediatrics the numbers are different. The fluid is an isotonic crystalloid, normal saline 0.9% NaCl or Ringer's lactate. The initial bolus is 20 mL/kg IV over 5 to 20 minutes. After each bolus, reassess perfusion by HR, cap refill, BP, mental status and urine output. The bolus is repeated up to 60 mL/kg in total if signs of shock persist, and if the shock is fluid-refractory, vasopressors such as dopamine or epinephrine are added.
After the initial bolus the question is no longer how much has been given but whether more will help, and fluid responsiveness is assessed dynamically rather than by static parameters. The measures named are the passive leg-raise, stroke-volume variation, pulse pressure variation, and ultrasound of the VTI or IVC. The monitoring tools are the arterial line for MAP, a CVP of 8-12 mmHg or less which is context-specific, lactate trends, and bedside echo or ultrasound of the IVC, with clinical, dynamic and biochemical data taken together. Perfusion is then reassessed by MAP, cap refill, lactate and ultrasound, and if the patient is non-responsive, norepinephrine is started early, since fluids and vasopressors should overlap, not sequence. The targets set beside this are a MAP of 65 mmHg or more, urine output of 0.5 mL/kg/h or more and a fall in lactate of 10% or more in 2-6 h, with a re-evaluation every 30-60 min and vasopressin added if norepinephrine goes above 0.3 µg/kg/min.